nach oben

Heart Failure Reviews

Erschienen in:

18.11.2019 | Pulmonary Hypertension

Long noncoding RNAs: emerging roles in pulmonary hypertension

verfasst von: Qi Jin, Zhihui Zhao, Qing Zhao, Xue Yu, Lu Yan, Yi Zhang, Qin Luo, Zhihong Liu

Erschienen in: Heart Failure Reviews | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Pulmonary hypertension (PH) is a complex and progressive disease characterized by increased pulmonary vascular resistance and pulmonary artery pressure, leading to pulmonary vascular remodeling, right heart failure, and ultimately death. Although several molecular pathways related to vascular remodeling have been reported, the mechanism behind this fatal disease with poor prognosis remains largely unclear. Long noncoding RNAs (lncRNAs) have been proven to be playing crucial roles in various biological processes, and emerging studies demonstrated lncRNAs as essential epigenetic modifiers involved in the onset and development of PH. The present review summarizes the types and biogenesis of lncRNAs, focuses on the biological function of lncRNAs in vascular diseases, and highlights all proven lncRNAs as well as highly potential lncRNA candidates involved in PH. Moreover, the interaction between lncRNA and corresponding miRNA in PH is also emphasized. Finally, we discuss current challenges and future prospects of lncRNAs as potential biomarkers and therapeutic targets for PH. Current data indicate lncRNAs are vital regulators of PH and may act as promising diagnostic and therapeutic targets for PH.

Galie N, Humbert M, Vachiery JL et al (2016) 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67–119PubMed

Sitbon O, Morrell N (2012) Pathways in pulmonary arterial hypertension: the future is here. Eur Respir Rev 21(126):321–327PubMed

Simonneau G, Montani D, Celermajer DS et al (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53(1):1801913

Humbert M, Guignabert C, Bonnet S et al (2019) Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J 53(1):1801887

Huang Z, Liu Z, Luo Q et al (2016) Glycoprotein 130 inhibitor ameliorates monocrotaline-induced pulmonary hypertension in rats. Can J Cardiol 32(11):1356 e1–1356e10

Morrell NW, Aldred MA, Chung WK et al (2019) Genetics and genomics of pulmonary arterial hypertension. Eur Respir J 53(1):1801899

Xiao JH, Hao QY, Wang K, Paul J, Wang YX (2017) Emerging role of microRNAs and long noncoding RNAs in healthy and diseased lung. Adv Exp Med Biol 967:343–359PubMed

Ponting CP, Oliver PL, Reik W (2009) Evolution and functions of long noncoding RNAs. Cell 136(4):629–641PubMed

Leeper NJ, Maegdefessel L (2018) Non-coding RNAs: key regulators of smooth muscle cell fate in vascular disease. Cardiovasc Res 114(4):611–621PubMed

10.

Haemmig S, Simion V, Feinberg MW (2018) Long Non-Coding RNAs in Vascular Inflammation. Front Cardiovasc Med 5:22PubMedPubMedCentral

11.

Kumar MM, Goyal R (2017) LncRNA as a therapeutic target for angiogenesis. Curr Top Med Chem 17(15):1750–1757PubMedPubMedCentral

12.

Yu B, Wang S (2018) Angio-lncRs: lncRNAs that regulate angiogenesis and vascular disease. Theranostics 8(13):3654–3675PubMedPubMedCentral

13.

Zheng Q, Lin Z, Xu J et al (2018) Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting beta-catenin by activating PKM2 and inactivating PTEN. Cell Death Dis 9(3):253PubMedPubMedCentral

14.

Gutschner T, Hammerle M, Eissmann M et al (2013) The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 73(3):1180–1189PubMed

15.

Shen S, Jiang H, Bei Y, Xiao J, Li X (2017) Long non-coding RNAs in cardiac remodeling. Cell Physiol Biochem 41(5):1830–1837PubMed

16.

Lorenzen JM, Thum T (2016) Long noncoding RNAs in kidney and cardiovascular diseases. Nat Rev Nephrol 12(6):360–373PubMed

17.

Liu Y, Zhang R, Ying K (2015) Long non-coding RNAs: novel links in respiratory diseases (review). Mol Med Rep 11(6):4025–4031PubMed

18.

Hermans-Beijnsberger S, van Bilsen M, Schroen B (2018) Long non-coding RNAs in the failing heart and vasculature. Noncoding RNA Res 3(3):118–130PubMedPubMedCentral

19.

Ballantyne MD, McDonald RA, Baker AH (2016) lncRNA/microRNA interactions in the vasculature. Clin Pharmacol Ther 99(5):494–501PubMedPubMedCentral

20.

Deng L, Bradshaw AC, Baker AH (2016) Role of noncoding RNA in vascular remodelling. Curr Opin Lipidol 27(5):439–448PubMed

21.

Quinn JJ, Chang HY (2016) Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 17(1):47–62PubMed

22.

Derrien T, Johnson R, Bussotti G et al (2012) The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22(9):1775–1789PubMedPubMedCentral

23.

Xiang Y, Zhang Y, Tang Y, Li Q (2017) MALAT1 modulates TGF-beta1-induced endothelial-to-mesenchymal transition through downregulation of miR-145. Cell Physiol Biochem 42(1):357–372PubMed

24.

Neumann P, Jae N, Knau A et al (2018) The lncRNA GATA6-AS epigenetically regulates endothelial gene expression via interaction with LOXL2. Nat Commun 9(1):237PubMedPubMedCentral

25.

Thomas AA, Biswas S, Feng B, Chen S, Gonder J, Chakrabarti S (2019) lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy. Diabetologia 62(3):517–530PubMed

26.

Bell RD, Long X, Lin M et al (2014) Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. Arterioscler Thromb Vasc Biol 34(6):1249–1259PubMedPubMedCentral

27.

Wang YN, Shan K, Yao MD et al (2016) Long noncoding RNA-GAS5: a novel regulator of hypertension-induced vascular remodeling. Hypertension (Dallas, Tex : 1979) 68(3):736–748PubMed

28.

Zhao J, Zhang W, Lin M et al (2016) MYOSLID is a novel serum response factor-dependent long noncoding RNA that amplifies the vascular smooth muscle differentiation program. Arterioscler Thromb Vasc Biol 36(10):2088–2099PubMedPubMedCentral

29.

Song TF, Huang LW, Yuan Y et al (2018) LncRNA MALAT1 regulates smooth muscle cell phenotype switch via activation of autophagy. Oncotarget 9(4):4411–4426PubMed

30.

Lino Cardenas CL, Kessinger CW, Cheng Y et al (2018) An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm. Nat Commun 9(1):1009PubMedPubMedCentral

31.

Ahmed ASI, Dong K, Liu J et al (2018) Long noncoding RNA NEAT1 (nuclear paraspeckle assembly transcript 1) is critical for phenotypic switching of vascular smooth muscle cells. Proc Natl Acad Sci U S A 115(37):E8660–E86E7PubMedPubMedCentral

32.

Zhang DD, Wang WT, Xiong J et al (2017) Long noncoding RNA LINC00305 promotes inflammation by activating the AHRR-NF-kappaB pathway in human monocytes. Sci Rep 7:46204PubMedPubMedCentral

33.

Jin L, Lin X, Yang L et al (2018) AK098656, a novel vascular smooth muscle cell-dominant long noncoding RNA, promotes hypertension. Hypertension (Dallas, Tex : 1979) 71(2):262–272PubMed

34.

Tian S, Yuan Y, Li Z, Gao M, Lu Y, Gao H (2018) LncRNA UCA1 sponges miR-26a to regulate the migration and proliferation of vascular smooth muscle cells. Gene 673:159–166PubMed

35.

Tang YY, Wo LK, Chai H (2013) Effects of noncoding RNA NRON gene regulation on human umbilical vein endothelial cells functions. Zhonghua xin xue guan bing za zhi 41(3):245–250PubMed

36.

Michalik KM, You X, Manavski Y et al (2014) Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res 114(9):1389–1397PubMed

37.

Liu JY, Yao J, Li XM et al (2014) Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis 5:e1506PubMedPubMedCentral

38.

Zhang X, Tang X, Hamblin MH, Yin KJ (2018) Long non-coding RNA Malat1 regulates angiogenesis in hindlimb ischemia. Int J Mol Sci 19(6):1723

39.

Yan B, Yao J, Liu JY et al (2015) lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res 116(7):1143–1156PubMed

40.

Fiedler J, Breckwoldt K, Remmele CW et al (2015) Development of long noncoding RNA-based strategies to modulate tissue vascularization. J Am Coll Cardiol 66(18):2005–2015PubMedPubMedCentral

41.

Kurian L, Aguirre A, Sancho-Martinez I et al (2015) Identification of novel long noncoding RNAs underlying vertebrate cardiovascular development. Circulation 131(14):1278–1290PubMedPubMedCentral

42.

Boulberdaa M, Scott E, Ballantyne M et al (2016) A role for the long noncoding RNA SENCR in commitment and function of endothelial cells. Mol Ther 24(5):978–990PubMedPubMedCentral

43.

Sun H, Wang S, Song M (2018) Long noncoding RNA SENCR alleviates the inhibitory effects of rapamycin on human umbilical vein endothelial cells. Mol Med Rep 18(2):1405–1414PubMedPubMedCentral

44.

Josipovic I, Fork C, Preussner J et al (2016) PAFAH1B1 and the lncRNA NONHSAT073641 maintain an angiogenic phenotype in human endothelial cells. Acta Physiol (Oxf) 218(1):13–27

45.

Ma Y, Wang P, Xue Y et al (2017) PVT1 affects growth of glioma microvascular endothelial cells by negatively regulating miR-186. Tumour Biol 39(3):1010428317694326PubMed

46.

Zheng J, Hu L, Cheng J et al (2018) lncRNA PVT1 promotes the angiogenesis of vascular endothelial cell by targeting miR26b to activate CTGF/ANGPT2. Int J Mol Med 42(1):489–496PubMed

47.

Leisegang MS, Fork C, Josipovic I et al (2017) Long noncoding RNA MANTIS facilitates endothelial angiogenic function. Circulation 136(1):65–79PubMedPubMedCentral

48.

He C, Yang W, Yang J et al (2017) Long Noncoding RNA MEG3 Negatively Regulates Proliferation and Angiogenesis in Vascular Endothelial Cells. DNA Cell Biol 36(6):475–481PubMed

49.

Ruan W, Zhao F, Zhao S, Zhang L, Shi L, Pang T (2018) Knockdown of long noncoding RNA MEG3 impairs VEGF-stimulated endothelial sprouting angiogenesis via modulating VEGFR2 expression in human umbilical vein endothelial cells. Gene 649:32–39PubMed

50.

Ma Y, Xue Y, Liu X et al (2017) SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153. Oncol Rep 38(5):3265–3277PubMed

51.

Bao MH, Li GY, Huang XS, Tang L, Dong LP, Li JM (2018) Long noncoding RNA LINC00657 acting as a miR-590-3p sponge to facilitate low concentration oxidized low-density lipoprotein-induced angiogenesis. Mol Pharmacol 93(4):368–375PubMed

52.

Wang Z, Wang R, Wang K, Liu X (2018) Upregulated long noncoding RNA Snhg1 promotes the angiogenesis of brain microvascular endothelial cells after oxygen-glucose deprivation treatment by targeting miR-199a. Can J Physiol Pharmacol 96(9):909–915PubMed

53.

Zhao M, Wang J, Xi X, Tan N, Zhang L (2018) SNHG12 promotes angiogenesis following ischemic stroke via regulating miR-150/VEGF pathway. Neuroscience 390:231–240PubMed

54.

Yin D, Fu C, Sun D (2018) Silence of lncRNA UCA1 represses the growth and tube formation of human microvascular endothelial cells through miR-195. Cell Physiol Biochem 49(4):1499–1511PubMed

55.

Halimulati M, Duman B, Nijiati J, Aizezi A (2018) Long noncoding RNA TCONS_00024652 regulates vascular endothelial cell proliferation and angiogenesis via microRNA-21. Exp Ther Med 16(4):3309–3316PubMedPubMedCentral

56.

Yin D, Li Y, Fu C, Feng Y (2018) Pro-angiogenic role of lncRNA HULC in microvascular endothelial cells via sequestrating miR-124. Cell Physiol Biochem 50(6):2188–2202PubMed

57.

Qin WW, Xin ZL, Wang HQ, Wang KP, Li XY, Wang X (2018) Inhibiting lncRNA ROR suppresses growth, migration and angiogenesis in microvascular endothelial cells by up-regulating miR-26. Eur Rev Med Pharmacol Sci 22(22):7985–7993PubMed

58.

Zhou Q, Yu B, Anderson C et al (2019) LncEGFL7OS regulates human angiogenesis by interacting with MAX at the EGFL7/miR-126 locus. Elife 8:e40470

59.

Man HSJ, Sukumar AN, Lam GC et al (2018) Angiogenic patterning by STEEL, an endothelial-enriched long noncoding RNA. Proc Natl Acad Sci U S A 115(10):2401–2406PubMedPubMedCentral

60.

Puthanveetil P, Chen S, Feng B, Gautam A, Chakrabarti S (2015) Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. J Cell Mol Med 19(6):1418–1425PubMedPubMedCentral

61.

Zhang X, Tang X, Liu K, Hamblin MH, Yin KJ (2017) Long noncoding RNA Malat1 regulates cerebrovascular pathologies in ischemic stroke. J Neurosci 37(7):1797–1806PubMedPubMedCentral

62.

Zhu X, Du J, Yu J et al (2019) LncRNA NKILA regulates endothelium inflammation by controlling a NF-kappaB/KLF4 positive feedback loop. J Mol Cell Cardiol 126:60–69PubMed

63.

Das S, Zhang E, Senapati P et al (2018) A novel angiotensin II-induced long noncoding RNA giver regulates oxidative stress, inflammation, and proliferation in vascular smooth muscle cells. Circ Res 123(12):1298–1312PubMedPubMedCentral

64.

Huang L, Li L, Yang T et al (2018) Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease. J Cell Mol Med 22(12):6249–6261PubMedPubMedCentral

65.

Dabral S, Tian X, Kojonazarov B et al (2016) Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension. Eur Respir J 48(4):1137–1149PubMed

66.

Kumar S, Williams D, Sur S, Wang JY, Jo H (2018) Role of flow-sensitive microRNAs and long noncoding RNAs in vascular dysfunction and atherosclerosis. Vascul Pharmacol 114:76-92

67.

Rossi MN, Antonangeli F (2014) LncRNAs: new players in apoptosis control. Int J Cell Biol 2014:473857PubMedPubMedCentral

68.

Eisenberg LM, Markwald RR (1995) Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 77(1):1–6PubMed

69.

Zeisberg EM, Tarnavski O, Zeisberg M et al (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13(8):952–961PubMed

70.

Evrard SM, Lecce L, Michelis KC et al (2016) Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat Commun 7:11853PubMedPubMedCentral

71.

Ranchoux B, Antigny F, Rucker-Martin C et al (2015) Endothelial-to-mesenchymal transition in pulmonary hypertension. Circulation 131(11):1006–1018PubMed

72.

Hulshoff MS, Xu X, Krenning G, Zeisberg EM (2018) Epigenetic regulation of endothelial-to-mesenchymal transition in chronic heart disease. Arterioscler Thromb Vasc Biol 38(9):1986–1996PubMed

73.

Huston JH, Ryan JJ (2016) The emerging role of epigenetics in pulmonary arterial hypertension: an important avenue for clinical trials (2015 Grover Conference Series). Pulm Circ 6(3):274–284PubMedPubMedCentral

74.

Potus F, Ruffenach G, Provencher S, Bonnet S (2015) Emerging role of epigenetic in pulmonary arterial hypertension right ventricular failure. FASEB J 29:1_supplement

75.

Brock M, Schuoler C, Leuenberger C et al (2017) Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation. Exp Biol Med (Maywood) 242(5):487–496

76.

Deng L. (2016) The role of non-coding RNA in the development of pulmonary arterial hypertension: University of Glasgow

77.

Brock M, Schuoler C, Ulrich S et al (2016) The long noncoding RNA MEG3 is an emerging factor in hypoxia-induced pulmonary hypertension. J Heart Lung Transplant 35(4):S358

78.

Sun Z, Nie X, Sun S et al (2017) Long non-coding RNA MEG3 downregulation triggers human pulmonary artery smooth muscle cell proliferation and migration via the p53 signaling pathway. Cell Physiol Biochem 42(6):2569–2581PubMed

79.

Zhu D, Xing Y, Zheng X et al (2018) Long noncoding RNA-maternally expressed gene 3 contributes to hypoxic pulmonary hypertension. bioRxiv:243063

80.

Zhu B, Gong Y, Yan G et al (2018) Down-regulation of lncRNA MEG3 promotes hypoxia-induced human pulmonary artery smooth muscle cell proliferation and migration via repressing PTEN by sponging miR-21. Biochem Biophys Res Commun 495(3):2125–2132PubMed

81.

Leisegang MS, Fork C, Josipovic I et al (2017) LncRNA MANTIS facilitates endothelial angiogenic function. Acta Physiol 219:59

82.

Puthenparampil HT, Jandl K, Wilhelm J et al (2017) Differentially expressed lncRNAs in IPAH: the impact of PAXIP1-AS1 on hPASMCs function. Wien Klin Wochenschr 129(19-20):755

83.

Jandl K, Thekkekara Puthenparampil H, Marsh LM et al (2018) Long non-coding RNAs influence the transcriptome in pulmonary arterial hypertension: the role of PAXIP1-AS1. J Pathol 247(3):357-370

84.

Chen J, Guo J, Cui X et al (2018) The long noncoding RNA lnRPT is regulated by PDGF-BB and modulates the proliferation of pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 58(2):181–193PubMed

85.

Chen J, Guo J, Chen J, Gou D (2018) The vascular LNCRNA VELRP defines an epigenetic checkpoint in hyperproliferation of pulmonary arterial smooth muscle cell. Am J Respir Crit Care Med:197 (Meeting Abstracts)

86.

Liu Y, Sun Z, Zhu J, Xiao B, Dong J, Li X (2018) LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism. J Cell Physiol 233(6):4801–4814PubMed

87.

Omura J, Peterlini T, Provencher S, Bonnet S (2018) Long noncoding RNA h19 in the development of pulmonary arterial hypertension and right ventricular failure. Am J Respir Crit Care Med:197 (Meeting Abstracts)

88.

Wang R, Zhou S, Wu P et al (2018) Identifying involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in treating pulmonary hypertension with melatonin. Mol Ther Nucleic Acids 13:44–54PubMedPubMedCentral

89.

Su H, Xu X, Yan C et al (2018) LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT1R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension. Respir Res 19(1):254PubMedPubMedCentral

90.

Zhang H, Liu Y, Yan L et al (2018) Long noncoding RNA Hoxaas3 contributes to hypoxia-induced pulmonary artery smooth muscle cell proliferation. Cardiovasc Res 115(3):647-657

91.

Zhu TT, Sun RL, Yin YL et al (2018) Long noncoding RNA UCA1 promotes the proliferation of hypoxic human pulmonary artery smooth muscle cells. Pflugers Arch 471(2):347-355

92.

Jiang Y, Mo H, Luo J et al (2018) HOTAIR is a potential novel biomarker in patients with congenital heart diseases. Biomed Res Int 2018:2850657PubMedPubMedCentral

93.

Josipovic I, Pfluger B, Fork C et al (2018) Long noncoding RNA LISPR1 is required for S1P signaling and endothelial cell function. J Mol Cell Cardiol 116:57–68PubMed

94.

Bischoff FC, Werner A, John D et al (2017) Identification and functional characterization of hypoxia-induced endoplasmic reticulum stress regulating lncRNA (HypERlnc) in pericytes. Circ Res 121(4):368–375PubMed

95.

Gong J, Chen Z, Chen Y et al (2019) Long non-coding RNA CASC2 suppresses pulmonary artery smooth muscle cell proliferation and phenotypic switch in hypoxia-induced pulmonary hypertension. Respir Res 20(1):53PubMedPubMedCentral

96.

Wang H, Qin R, Cheng Y (2019) LncRNA-Ang362 promotes pulmonary arterial hypertension by regulating miR-221 and miR-222. Shock. https://doi.org/10.1097/SHK.0000000000001410

97.

Yang L, Liang H, Shen L, Guan Z, Meng X (2019) LncRNA Tug1 involves in the pulmonary vascular remodeling in mice with hypoxic pulmonary hypertension via the microRNA-374c-mediated Foxc1. Life Sci 237:116769

98.

Bekri S, Adelaide J, Merscher S et al (1997) Detailed map of a region commonly amplified at 11q13-- > q14 in human breast carcinoma. Cytogenet Cell Genet 79(1-2):125–131PubMed

99.

Ji P, Diederichs S, Wang W et al (2003) MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22(39):8031–8041PubMed

100.

Comer BS, Ba M, Singer CA, Gerthoffer WT (2015) Epigenetic targets for novel therapies of lung diseases. Pharmacol Ther 147:91–110PubMed

101.

Xu C, Yang M, Tian J, Wang X, Li Z (2011) MALAT-1: a long non-coding RNA and its important 3′ end functional motif in colorectal cancer metastasis. Int J Oncol 39(1):169–175PubMed

102.

Lai MC, Yang Z, Zhou L et al (2012) Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 29(3):1810–1816PubMed

103.

Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F (2012) Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol BioSyst 8(9):2289–2294PubMed

104.

Lin R, Roychowdhury-Saha M, Black C et al (2011) Control of RNA processing by a large non-coding RNA over-expressed in carcinomas. FEBS Lett 585(4):671–676PubMedPubMedCentral

105.

Zhuo Y, Zeng Q, Zhang P, Li G, Xie Q, Cheng Y (2017) Functional polymorphism of lncRNA MALAT1 contributes to pulmonary arterial hypertension susceptibility in Chinese people. Clin Chem Lab Med 55(1):38–46PubMed

106.

Li Q, Zhu W, Zhang B et al (2018) The MALAT1 gene polymorphism and its relationship with the onset of congenital heart disease in Chinese. Biosci Rep 38(3): BSR20171381

107.

Brock M, Schuoler C, Haider T et al (2016) Detection and characterization of long noncoding RNAs in hypoxia-induced pulmonary hypertension. Eur Respir J 48: OA3009

108.

Zhang CY, Yu MS, Li X, Zhang Z, Han CR, Yan B (2017) Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway. Tumour Biol 39(6):1010428317701311PubMed

109.

Piccoli MT, Gupta SK, Viereck J et al (2017) Inhibition of the cardiac fibroblast-enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction. Circ Res 121(5):575–583PubMed

110.

Mizuno S, Bogaard HJ, Kraskauskas D et al (2011) p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice. Am J Physiol Lung Cell Mol Physiol 300(5):L753–L761PubMed

111.

Mouraret N, Marcos E, Abid S et al (2013) Activation of lung p53 by Nutlin-3a prevents and reverses experimental pulmonary hypertension. Circulation 127(16):1664–1676PubMedPubMedCentral

112.

Fish JE, Yan MS, Matouk CC et al (2010) Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones. J Biol Chem 285(2):810–826PubMed

113.

Weirick T, Militello G, Ponomareva Y et al (2018) Logic programming to infer complex RNA expression patterns from RNA-seq data. Brief Bioinform 19(2):199–209PubMed

114.

Veith C, Marsh LM, Wygrecka M et al (2012) Paxillin regulates pulmonary arterial smooth muscle cell function in pulmonary hypertension. Am J Pathol 181(5):1621–1633PubMed

115.

Grimminger F, Schermuly RT (2010) PDGF receptor and its antagonists: role in treatment of PAH. Adv Exp Med Biol 661:435–446PubMed

116.

Oldham WM (2018) The long noncoding RNA lnRPT puts the brakes on pulmonary artery smooth muscle cell proliferation. Am J Respir Cell Mol Biol 58(2):138–139PubMedPubMedCentral

117.

Ducat A, Doridot L, Calicchio R et al (2016) Endothelial cell dysfunction and cardiac hypertrophy in the STOX1 model of preeclampsia. Sci Rep 6:19196PubMedPubMedCentral

118.

Wang J, Wang X, Chen T, Jiang L, Yang Q (2017) Huaier extract inhibits breast cancer progression through a lncRNA-H19/MiR-675-5p pathway. Cell Physiol Biochem 44(2):581–593PubMed

119.

Matouk IJ, Halle D, Gilon M, Hochberg A (2015) The non-coding RNAs of the H19-IGF2 imprinted loci: a focus on biological roles and therapeutic potential in Lung Cancer. J Transl Med 13:113PubMedPubMedCentral

120.

Liu L, An X, Li Z et al (2016) The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy. Cardiovasc Res 111(1):56–65PubMed

121.

Gomez J, Lorca R, Reguero JR et al (2018) Genetic variation at the long noncoding RNA H19 gene is associated with the risk of hypertrophic cardiomyopathy. Epigenomics 10(7):865–873PubMed

122.

Pearson JC, Lemons D, McGinnis W (2005) Modulating Hox gene functions during animal body patterning. Nat Rev Genet 6(12):893–904PubMed

123.

Wang XS, Zhang Z, Wang HC et al (2006) Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res 12(16):4851–4858PubMed

124.

He A, Hu R, Chen Z et al (2017) Role of long noncoding RNA UCA1 as a common molecular marker for lymph node metastasis and prognosis in various cancers: a meta-analysis. Oncotarget 8(1):1937–1943PubMed

125.

Liu Y, Zhou D, Li G et al (2015) Long non coding RNA-UCA1 contributes to cardiomyocyte apoptosis by suppression of p27 expression. Cell Physiol Biochem 35(5):1986–1998PubMed

126.

Zhou G, Li C, Feng J, Zhang J, Fang Y (2018) lncRNA UCA1 Is a novel regulator in cardiomyocyte hypertrophy through targeting the miR-184/HOXA9 axis. Cardiorenal Med 8(2):130–139PubMedPubMedCentral

127.

Reiner O, Carrozzo R, Shen Y et al (1993) Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature 364(6439):717–721PubMed

128.

Rinn JL, Kertesz M, Wang JK et al (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129(7):1311–1323PubMedPubMedCentral

129.

Bhan A, Mandal SS (2015) LncRNA HOTAIR: a master regulator of chromatin dynamics and cancer. Biochim Biophys Acta 1856(1):151–164PubMedPubMedCentral

130.

Lai Y, He S, Ma L et al (2017) HOTAIR functions as a competing endogenous RNA to regulate PTEN expression by inhibiting miR-19 in cardiac hypertrophy. Mol Cell Biochem 432(1-2):179–187PubMed

131.

Gao L, Liu Y, Guo S et al (2017) Circulating long noncoding RNA HOTAIR is an essential mediator of acute myocardial infarction. Cell Physiol Biochem 44(4):1497–1508PubMed

132.

Kimura T, Watanabe T, Sato K et al (2000) Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem J 348(Pt 1):71–76PubMedPubMedCentral

133.

Purschke WG, Hoehlig K, Buchner K et al (2014) Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis. Biochem J 462(1):153–162PubMedPubMedCentral

134.

Chen J, Tang H, Sysol JR et al (2014) The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension. Am J Respir Crit Care Med 190(9):1032–1043PubMedPubMedCentral

135.

Koyama M, Furuhashi M, Ishimura S et al (2014) Reduction of endoplasmic reticulum stress by 4-phenylbutyric acid prevents the development of hypoxia-induced pulmonary arterial hypertension. Am J Phys Heart Circ Phys 306(9):H1314–H1323

136.

Wang JJ, Zuo XR, Xu J et al (2016) Evaluation and treatment of endoplasmic reticulum (ER) stress in right ventricular dysfunction during monocrotaline-induced rat pulmonary arterial hypertension. Cardiovasc Drugs Ther 30(6):587–598PubMed

137.

Wang Y, Liu Z, Yao B et al (2017) Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Mol Cancer 16(1):123PubMedPubMedCentral

138.

Zhang L, Cheng H, Yue Y, Li S, Zhang D, He R (2018) TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1. Cardiovasc Pathol 33:6–15PubMed

139.

Gu S, Li G, Zhang X et al (2015) Aberrant expression of long noncoding RNAs in chronic thromboembolic pulmonary hypertension. Mol Med Rep 11(4):2631–2643PubMed

140.

Wang M, Gu S, Liu Y et al (2019) miRNA-PDGFRB/HIF1A-lncRNA CTEPHA1 network plays important roles in the mechanism of chronic thromboembolic pulmonary hypertension. Int Heart J 60(4):924–937PubMed

141.

Wang X, Yan C, Xu X et al (2016) Long noncoding RNA expression profiles of hypoxic pulmonary hypertension rat model. Gene 579(1):23–28PubMed

142.

Cao Y, Yang Y, Wang L et al (2018) Analyses of long non-coding RNA and mRNA profiles in right ventricle myocardium of acute right heart failure in pulmonary arterial hypertension rats. Biomed Pharmacother 106:1108–1115PubMed

143.

Sun Z, Liu Y, Yu F, Xu Y, Yanli L, Liu N (2019) Long non-coding RNA and mRNA profile analysis of metformin to reverse the pulmonary hypertension vascular remodeling induced by monocrotaline. Biomed Pharmacother 115:108933PubMed

144.

Leung A, Trac C, Jin W et al (2013) Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res 113(3):266–278PubMedPubMedCentral

145.

Lyu Q, Xu S, Lyu Y et al (2019) SENCR stabilizes vascular endothelial cell adherens junctions through interaction with CKAP4. Proc Natl Acad Sci U S A 116(2):546–555PubMed

146.

Lu W, Huang SY, Su L, Zhao BX, Miao JY (2016) Long noncoding RNA LOC100129973 suppresses apoptosis by targeting miR-4707-5p and miR-4767 in vascular endothelial cells. Sci Rep 6:21620PubMedPubMedCentral

147.

Teng W, Qiu C, He Z, Wang G, Xue Y, Hui X (2017) Linc00152 suppresses apoptosis and promotes migration by sponging miR-4767 in vascular endothelial cells. Oncotarget 8(49):85014–85023PubMedPubMedCentral

148.

Li L, Wang M, Mei Z et al (2017) lncRNAs HIF1A-AS2 facilitates the up-regulation of HIF-1alpha by sponging to miR-153-3p, whereby promoting angiogenesis in HUVECs in hypoxia. Biomed Pharmacother 96:165–172PubMed

149.

Congrains A, Kamide K, Oguro R et al (2012) Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis 220(2):449–455PubMed

150.

Motterle A, Pu X, Wood H et al (2012) Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells. Hum Mol Genet 21(18):4021–4029PubMedPubMedCentral

151.

Wu G, Cai J, Han Y et al (2014) LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation 130(17):1452–1465PubMedPubMedCentral

152.

Ma Y, Huang D, Yang F et al (2016) Long noncoding RNA highly upregulated in liver cancer regulates the tumor necrosis factor-alpha-induced apoptosis in human vascular endothelial cells. DNA Cell Biol 35(6):296–300PubMed

153.

Ballantyne MD, Pinel K, Dakin R et al (2016) Smooth muscle enriched long noncoding RNA (SMILR) regulates cell proliferation. Circulation 133(21):2050–2065PubMedPubMedCentral

154.

Shan K, Jiang Q, Wang XQ et al (2016) Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction. Cell Death Dis 7(6):e2248PubMedPubMedCentral

155.

Lin Z, Ge J, Wang Z et al (2017) Let-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk. Sci Rep 7:42498PubMedPubMedCentral

156.

Zhang BY, Jin Z, Zhao Z (2017) Long intergenic noncoding RNA 00305 sponges miR-136 to regulate the hypoxia induced apoptosis of vascular endothelial cells. Biomed Pharmacother 94:238–243PubMed

157.

Li H, Liu X, Zhang L, Li X (2017) LncRNA BANCR facilitates vascular smooth muscle cell proliferation and migration through JNK pathway. Oncotarget 8(70):114568–114575PubMedPubMedCentral

158.

Liao B, Chen R, Lin F et al (2018) Long noncoding RNA HOTTIP promotes endothelial cell proliferation and migration via activation of the Wnt/beta-catenin pathway. J Cell Biochem 119(3):2797–2805PubMed

159.

Zhang Y, Zheng L, Xu BM et al (2018) LncRNA-RP11-714G18.1 suppresses vascular cell migration via directly targeting LRP2BP. Immunol Cell Biol 96(2):175–189PubMed

160.

Yao X, Yan C, Zhang L, Li Y, Wan Q (2018) LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis. Medicine 97(16):e0473PubMedPubMedCentral

161.

Natarelli L, Geissler C, Csaba G et al (2018) miR-103 promotes endothelial maladaptation by targeting lncWDR59. Nat Commun 9(1):2645PubMedPubMedCentral

162.

Miao C, Cao H, Zhang Y, Guo X, Wang Z, Wang J (2018) LncRNA DIGIT accelerates tube formation of vascular endothelial cells by sponging miR-134. Int Heart J 59(5):1086–1095PubMed

163.

Wang H, Jin Z, Pei T et al (2019) Long noncoding RNAs C2dat1 enhances vascular smooth muscle cell proliferation and migration by targeting MiR-34a-5p. J Cell Biochem 120(3):3001–3008PubMed

164.

Wang X, Zhao Z, Zhang W, Wang Y (2019) Long noncoding RNA LINC00968 promotes endothelial cell proliferation and migration via regulating miR-9-3p expression. J Cell Biochem 120: 8214‐8221

165.

Li S, Sun Y, Zhong L et al (2018) The suppression of ox-LDL-induced inflammatory cytokine release and apoptosis of HCAECs by long non-coding RNA-MALAT1 via regulating microRNA-155/SOCS1 pathway. Nutr Metab Cardiovasc Dis 28(11):1175–1187PubMed

166.

Cremer S, Michalik KM, Fischer A et al (2019) Hematopoietic deficiency of the long noncoding RNA MALAT1 promotes atherosclerosis and plaque inflammation. Circulation 139(10):1320–1334PubMed

167.

Zhang Y, Liu X, Bai X et al (2018) Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis. J Pineal Res 64(2):e12449

168.

Wang S, Zhang X, Yuan Y et al (2015) BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro. Eur J Cardiothorac Surg 47(3):439–446PubMed

169.

Li DY, Busch A, Jin H et al (2018) H19 induces abdominal aortic aneurysm development and progression. Circulation 138(15):1551–1568PubMedPubMedCentral

170.

Greco S, Zaccagnini G, Fuschi P et al (2017) Increased BACE1-AS long noncoding RNA and beta-amyloid levels in heart failure. Cardiovasc Res 113(5):453–463PubMed

171.

Zou ZQ, Xu J, Li L, Han YS (2015) Down-regulation of SENCR promotes smooth muscle cells proliferation and migration in db/db mice through up-regulation of FoxO1 and TRPC6. Biomed Pharmacother 74:35–41PubMed

172.

Zhang XY, Tang XY, Li N et al (2018) GAS5 promotes airway smooth muscle cell proliferation in asthma via controlling miR-10a/BDNF signaling pathway. Life Sci 212:93–101PubMed

173.

Austin PJ, Tsitsiou E, Boardman C et al (2017) Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype in human airway smooth muscle. J Allergy Clin Immunol 139(3):780–789PubMedPubMedCentral

174.

Yu X, Zhe Z, Tang B et al (2017) alpha-Asarone suppresses the proliferation and migration of ASMCs through targeting the lncRNA-PVT1/miR-203a/E2F3 signal pathway in RSV-infected rats. Acta Biochim Biophys Sin (Shanghai) 49(7):598–608

175.

Maron BA, Leopold JA (2014) The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series). Pulm Circ 4(2):200–210PubMedPubMedCentral

176.

Xu Y, Bei Y, Shen S et al (2017) MicroRNA-222 promotes the proliferation of pulmonary arterial smooth muscle cells by targeting P27 and TIMP3. Cell Physiol Biochem 43(1):282–292PubMed

177.

Nie X, Chen Y, Tan J et al (2017) MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension. Vasc Pharmacol 116:24-35

178.

Yoon JH, Abdelmohsen K, Gorospe M (2014) Functional interactions among microRNAs and long noncoding RNAs. Semin Cell Dev Biol 34:9–14PubMed

179.

Thomson DW, Dinger ME (2016) Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet 17(5):272–283PubMed

180.

Wang D, Xu H, Wu B et al (2019) Long noncoding RNA MALAT1 sponges miR1243p.1/KLF5 to promote pulmonary vascular remodeling and cell cycle progression of pulmonary artery hypertension. Int J Mol Med 44(3):871–884PubMedPubMedCentral

181.

Dalvi P, O'Brien-Ladner A, Dhillon NK (2013) Downregulation of bone morphogenetic protein receptor axis during HIV-1 and cocaine-mediated pulmonary smooth muscle hyperplasia: implications for HIV-related pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol 33(11):2585–2595PubMed

182.

Chinnappan M, Dalvi P, Dhillon NK (2017) Micro-RNA 216a mediated post-transcriptional regulation of bone morphogenetic protein receptor 2 expression in cocaine and HIV Tat exposed pulmonary smooth muscle cells. C34 Mechanisms of Host Defense in Bacterial and Fungal Infections: American Thoracic Society: A5274-A

183.

Chinnappan M, Mohan A, Agarwal S, Dalvi P, Dhillon NK (2018) Network of microRNAs mediate translational repression of bone morphogenetic protein receptor-2: involvement in HIV-associated pulmonary vascular remodeling. J Am Heart Assoc 7(5):e008472

184.

Chinnappan M, Mohan A, Chalise P, Koestler D, Dhillon NK (2018) Differential expression of long noncoding RNAs in cocaine and HIV-1 Tat treated pulmonary smooth muscle cells. Am J Respir Crit Care Med:197 (Meeting Abstracts)

185.

Chinnappan M, Gunewardena S, Chalise P, Dhillon NK (2019) Analysis of lncRNA-miRNA-mRNA interactions in hyper-proliferative human pulmonary arterial smooth muscle cells. Sci Rep 9(1):10533PubMedPubMedCentral

186.

Yin Q, Wu A, Liu M (2017) Plasma Long non-coding RNA (lncRNA) GAS5 is a new biomarker for coronary artery disease. Med Sci Monit 23:6042–6048PubMedPubMedCentral

187.

Kumarswamy R, Bauters C, Volkmann I et al (2014) Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res 114(10):1569–1575PubMed

188.

Gu M, Zheng A, Tu W et al (2016) Circulating LncRNAs as novel, non-invasive biomarkers for prenatal detection of fetal congenital heart defects. Cell Physiol Biochem 38(4):1459–1471PubMed

189.

Schlosser K, Stewart DJ (2015) Limited potential of circulating long non-coding RNAs as biomarkers for pulmonary arterial hypertension. Can J Cardiol 31(10):S38–SS9

190.

Schlosser K, Hanson J, Villeneuve PJ et al (2016) Assessment of circulating lncRNAs under physiologic and pathologic conditions in humans reveals potential limitations as biomarkers. Sci Rep 6:36596PubMedPubMedCentral

191.

Smaldone MC, Davies BJ (2010) BC-819, a plasmid comprising the H19 gene regulatory sequences and diphtheria toxin A, for the potential targeted therapy of cancers. Curr Opin Mol Ther 12(5):607–616PubMed

192.

Halachmi S, Leibovitch I, Zisman A et al (2018) Phase II trial of BC-819 intravesical gene therapy in combination with BCG in patients with non-muscle invasive bladder cancer (NMIBC). J Clin Oncol 36(6_suppl):499

193.

Viereck J, Kumarswamy R, Foinquinos A et al (2016) Long noncoding RNA Chast promotes cardiac remodeling. Sci Transl Med 8(326):326ra22PubMed

194.

Lennox KA, Behlke MA (2016) Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides. Nucleic Acids Res 44(2):863–877PubMed

195.

Johnsson P, Lipovich L, Grander D, Morris KV (2014) Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim Biophys Acta 1840(3):1063–1071PubMed

196.

Amaral PP, Leonardi T, Han N et al (2018) Genomic positional conservation identifies topological anchor point RNAs linked to developmental loci. Genome Biol 19(1):32PubMedPubMedCentral

197.

Kirk JM, Kim SO, Inoue K et al (2018) Functional classification of long non-coding RNAs by k-mer content. Nat Genet 50(10):1474–1482PubMedPubMedCentral

Titel: Long noncoding RNAs: emerging roles in pulmonary hypertension
verfasst von: Qi Jin
Zhihui Zhao
Qing Zhao
Xue Yu
Lu Yan
Yi Zhang
Qin Luo
Zhihong Liu
Publikationsdatum: 18.11.2019
Verlag: Springer US
Schlagwörter: Pulmonary Hypertension
Pulmonary Hypertension
Erschienen in: Heart Failure Reviews / Ausgabe 5/2020
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-019-09866-2

Neu im Fachgebiet Kardiologie

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Chronisches Koronarsyndrom: Gefahr von Hospitalisierung wegen Herzinsuffizienz

06.05.2024 Herzinsuffizienz Nachrichten

Obwohl ein rezidivierender Herzinfarkt bei chronischem Koronarsyndrom wahrscheinlich die Hauptsorge sowohl der Patienten als auch der Ärzte ist, sind andere Ereignisse womöglich gefährlicher. Laut einer französischen Studie stellt eine Hospitalisation wegen Herzinsuffizienz eine größere Gefahr dar.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2020

Adult congenital heart disease with pulmonary arterial hypertension: mechanisms and management

Anti-fibrotic effects of curcumin and some of its analogues in the heart

Correction to: Crosstalk between GSK-3β-actuated molecular cascades and myocardial physiology

Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation?